Form 4 for TECH Bio-Techne
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-15 · accession 0001062993-23-016707 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-17 | 2023-08-15 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $84.61 | -8,675 | 1.28M | -0.7% | -$734.0K |
| D | 2023-08-17 | 2023-08-15 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $0.00 | +17.6K | 1.29M | +1% | $0 |
| D | 2023-08-17 | 2023-08-15 | TECH | Kummeth Charles R. | CEO, Dir | A - Grant | $0.00 | +59.1K | 59.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-15 | F | D | 8,675 | $84.61 | 1,278,269 | D | — | — | (F1) Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024. |
| 2 | Common | Common Stock | 2023-08-15 | M | A | 17,632 | $0.00 | 1,286,944 | D | — | — | (F1) Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024. |
| 3 | Derivative | Restricted Stock Units | 2023-08-15 | A | A | 59,095 | $0.00 | 59,095 | D | — · — to — | 59,095 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F9) 19,698 shares vest on each of 8/15/2024 and 8/15/2026, and 19,699 shares vest on 8/15/2025. |